US-based Akston Biosciences initiates Ph II trial of second-gen COVID-19 vaccine in India

Readouts expected by January 2022

Related Keywords

India , ,Akston Biosciences Corporation ,Ministry Of Health ,Veeda Clinical Research Ltd ,Research Centre ,Controller General ,Family Welfare ,Supe Heart ,Diabetes Hospital ,Clinical Trial ,Akston Biosciences ,Covid Vaccine ,